Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study (original) (raw)

Clinical Trials: New Opportunities

Sandra Chapman

The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2012

View PDFchevron_right

Criteria of Patient Selection in a Clinical Trial

Michel Bourin

SOJ Pharmacy & Pharmaceutical Sciences

View PDFchevron_right

Patient attitudes to clinical trials: development of a questionnaire and results from asthma and cancer patients

Sherwood Burge

Health Expectations, 2005

View PDFchevron_right

(Re)configuring research value: international commercial clinical trials in the Russian Federation

Nora Engel

BioSocieties, 2017

View PDFchevron_right

Varying ethics rules in clinical research and routine patient care – research ethics committee chairpersons’ views in Finland

piret veerus

Health Research Policy and Systems, 2014

View PDFchevron_right

Randomized clinical trial

Steven Budsberg

European Journal of Gastroenterology & Hepatology, 2012

View PDFchevron_right

The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales

Su-I Hou

Journal of Clinical Epidemiology, 2010

View PDFchevron_right

Who is willing to participate in low-risk pragmatic clinical trials without consent?

Rafael Dal-Ré

European Journal of Clinical Pharmacology, 2017

View PDFchevron_right

Knowledge and perceptions of research participants in Nigeria about clinical trials

Theresa Rossouw

Indian Journal of Medical Ethics, 2015

View PDFchevron_right

The Globalization of Clinical Trials for New Medicines: Where are the Trials Going and Why?

Iain Cockburn

2007

View PDFchevron_right

When Clinical Trials Are Compromised: A Perspective from a Patient Advocate

Musa Mayer

PLoS Medicine, 2005

View PDFchevron_right

Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve

Melanie Wright

BMJ Quality & Safety, 2010

View PDFchevron_right

Practices, patients and (im)perfect data - feasibility of a randomised controlled clinical drug trial in German general practices

Karl Wegscheider

Trials, 2011

View PDFchevron_right

International models of investigator-initiated trials: implications for Japan

Naoko Takebe

Annals of Oncology, 2012

View PDFchevron_right

Staff beliefs about drug abuse clinical trials

Gregory Bovasso

Journal of Substance Abuse Treatment, 2002

View PDFchevron_right

Choice of Evaluation Criteria in a Clinical Trial

Michel Bourin

SOJ Pharmacy & Pharmaceutical Sciences, 2016

View PDFchevron_right

It's Time to Harmonize Clinical Trial Site Standards

Greg Koski

NAM Perspectives, 2017

View PDFchevron_right

Clinical Trials in the Balkan Region: Still Under-Discovered Potential?

Halima Resić

2009

View PDFchevron_right

Factors affecting patient participation in clinical trials in Ireland: A narrative review

Ann Sheridan

Contemporary Clinical Trials Communications, 2016

View PDFchevron_right

Steps and time to process clinical trials at the Cancer Therapy Evaluation Program

Steven Cheng

2009

View PDFchevron_right

Qualitative features in clinical trials: coordinates for prevention of passive and active misconduct

Theresa Bromley

International Journal of Clinical Trials, 2018

View PDFchevron_right

Knowledge, Attitudes and Perceptions of Saudis towards Participating in Clinical Trials

Nahid El-Bakri

PLOS ONE, 2016

View PDFchevron_right

Ethics in Clinical Research: Is Ethics Involved Into the Pharmacy Studies in Europe?

Michal Vivoda

CBU International Conference Proceedings 2013 - Integration and Innovation in Science and Education, 2013

View PDFchevron_right

Integrating qualitative research within a clinical trials unit: developing strategies and understanding their implementation in contexts

Eleni Glarou

Trials, 2024

View PDFchevron_right

Patient Perspectives on Phase 0 Clinical Trials

Deborah E Collyar

Clinical Cancer Research, 2008

View PDFchevron_right

Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study

M. Campbell, David L. Francis

Health Technology Assessment, 2007

View PDFchevron_right

The need to implement non-industry COVID-19 clinical trials in non-high-income countries

Rafael Dal-Ré

Journal of Global Health, 2020

View PDFchevron_right

Evidence-based medicine in Norway

Eivind Engebretsen

2019

View PDFchevron_right

Consent to clinical trials in anaesthesia

John R O B E R T Sneyd

Anaesthesia, 1998

View PDFchevron_right

Interactions of doctors with the pharmaceutical industry

Jay Schulkin

Journal of Medical Ethics, 2006

View PDFchevron_right

Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect

Barbara Mintzes

British Medical Bulletin, 2015

View PDFchevron_right

Enhancing clinical trials on the internet: Lessons from INVEST

Carl Pepine

Clinical Cardiology, 2009

View PDFchevron_right

Costs, effects and C/E-ratios alongside a clinical trial

Ben Van Hout

Health Economics, 1994

View PDFchevron_right

Clinicians as Researchers

Dr. Arvie Vitente

Philippine journal of physical therapy, 2023

View PDFchevron_right

International trials in middle-income countries: different local scenarios require different ethical approaches

Rafael Dal-Ré

Journal of the Royal Society of Medicine, 2015

View PDFchevron_right